Literature DB >> 369255

Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculation.

B J Whittle, S Moncada, J R Vane.   

Abstract

Prostacyclin, generated by the vascular wall, is a potent vasodilator, reducing systemic blood pressure, increasing coronary blood flow and relaxing isolated vascular strips. Its vasoactive properties are little changed by passage through the lung. Prostacyclin, which is also formed by the gastric mucosa, increases gastric mucosal blood flow and inhibits gastric acid secretion and indomethacin-induced erosions. It is the most potent inhibitor of platelet aggregation in all species tested. It is suggested that prostacyclin and PGE1 act on similar sites on platelets distinct from those for PGD2.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 369255

Source DB:  PubMed          Journal:  Acta Biol Med Ger        ISSN: 0001-5318


  3 in total

1.  Mucosal prostaglandin levels of the gastric stump.

Authors:  I Dobó; K Tihanyi; J Banai; I Szántó; I Rózsa
Journal:  Gastroenterol Jpn       Date:  1988-10

2.  Anti-aggregatory effect of prostacyclin (PGI2) in vivo.

Authors:  B L Bayer; K E Blass; W Förster
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

3.  Different effects of prostacyclin and phentolamine on delivery-dependent O2 consumption and skin microcirculation after cardiac surgery.

Authors:  J F Pittet; J S Lacroix; K Gunning; A Déom; P Neidhart; D R Morel; P M Suter
Journal:  Can J Anaesth       Date:  1992-12       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.